Biomaterial Database

IBD: Tofacitinib effective in ulcerative colitis. 2017

Conor A Bradley

UI	MeSH Term	Description	Entries
D010880	Piperidines	A family of hexahydropyridines.
D011743	Pyrimidines	A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D011758	Pyrroles	Azoles of one NITROGEN and two double bonds that have aromatic chemical properties.	Pyrrole
D003093	Colitis, Ulcerative	Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.	Colitis Gravis,Idiopathic Proctocolitis,Inflammatory Bowel Disease, Ulcerative Colitis Type,Ulcerative Colitis
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Conor A Bradley

Tofacitinib in ulcerative colitis.

May 2016, Immunotherapy,

Conor A Bradley

Tofacitinib in active ulcerative colitis.

November 2012, The New England journal of medicine,

Conor A Bradley

Tofacitinib in active ulcerative colitis.

November 2012, The New England journal of medicine,

Conor A Bradley

Tofacitinib in Ulcerative Colitis: Beyond Biologics?

December 2023, Inflammatory bowel diseases,

Conor A Bradley

Safety and effectiveness of tofacitinib in ulcerative colitis: Data from TOFA-UC, a SN-IBD study.

January 2024, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver,

Conor A Bradley

Efficacy of tofacitinib treatment in ulcerative colitis.

January 2019, Gastroenterologia y hepatologia,

Conor A Bradley

Tofacitinib: janus bifrons in ulcerative colitis treatment.

May 2013, Gastroenterology,

Conor A Bradley

Clinical settings with tofacitinib in ulcerative colitis.

April 2022, Revista espanola de enfermedades digestivas,

Conor A Bradley

Reply: Tofacitinib in Ulcerative Colitis: Beyond Biologics?

December 2023, Inflammatory bowel diseases,